paranasal sinus Schneiderian papilloma

Summary

paranasal sinus Schneiderian papilloma (MONDO:0006353) is a disease. A subtype of respiratory system benign neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	paranasal sinus Schneiderian papilloma
Mondo ID	MONDO:0006353
NCIT	C6835
UMLS	C1335343
MedGen	235462
GARD	0024380
Is cancer (heuristic)	no

Also known as: paranasal sinus Schneiderian papilloma

Disease family

This is a subtype of respiratory system benign neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › respiratory system disorder › respiratory system benign neoplasm › paranasal sinus Schneiderian papilloma

Related subtypes (14): endobronchial lipoma, benign laryngeal neoplasm, lung benign neoplasm, benign neoplasm of pleura, benign neoplasm of hypopharynx, benign neoplasm of nasal cavity, benign neoplasm of sphenoidal sinus, benign neoplasm of nasopharynx, benign neoplasm of oropharynx, benign neoplasm of frontal sinus, benign neoplasm of maxillary sinus, benign neoplasm of tonsil, benign neoplasm of ethmoidal sinus, benign neoplasm of trachea

Subtypes (4): frontal sinus Schneiderian papilloma, ethmoid sinus Schneiderian papilloma, sphenoid sinus Schneiderian papilloma, maxillary sinus Schneiderian papilloma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.